Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin plus tolterodine versus desmopressin plus indomethacin for pediatric enuresis
IRCT20210613051564N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of desmopressin, tolterodine and indomethacin in nocturnal enuresis (NE) (2 arms), sponsored by Hormozgan University of Medical Sciences. Started Mar 2018; status: completed.
02
Drugs
desmopressintolterodineindomethacin
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on IRCT20210613051564N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210613051564N1.